Company / Financials
AbbVie Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$61.2B
FY2025 · +8.6% YoY
Net Income
$4.2B
FY2025 · -1.2% YoY
Profit Margin
6.9%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$134.0B
FY2025
Total Debt
$64.5B
-19.73x debt/equity
Equity
-$3.3B
FY2025
ROA
3.1%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$61.2B+8.6% YoYNet Income HistoryProfit after all expenses and taxes$4.2B-1.2% YoYGross Profit HistoryRevenue minus cost of goods sold$6.0BCost of Revenue HistoryDirect costs of producing goods and services sold$18.2B+7.7% YoYOperating Income HistoryProfit from core business operations before interest and taxes$15.1B+65.0% YoYSG&A Expense HistorySelling, general, and administrative expenses$14.0B-5.0% YoYR&D Expense HistoryResearch and development spending$9.1B-28.9% YoYInterest Expense HistoryCost of borrowing and debt obligations$2.9B+3.0% YoYIncome Tax HistoryTotal income tax expense$2.4B+514.7% YoYEPS (Basic) HistoryBasic earnings per share$2.73-58.9% YoY